5-Oxoproline Enhances 4-Hydroxytamoxifen-Induced Cytotoxicity by Increasing Oxidative Stress in MCF-7 Breast Cancer Cells

Researchers evaluated the combined effect of monocarboxylate transporter inhibitors and 4-hydroxytamoxifen using the estrogen receptor-positive breast cancer cell line MCF-7, under normal glucose conditions.